Skip to Main Content

Paper Details

Identification and Validation of Leucine-rich α-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification.
Eur Urol Open Sci
12
2020
LRG1, Leucine, Leucine-rich -2-glycoprotein 1, Patient, Prostate Cancer, blood, leucine, metastatic prostate cancer, participants, patient, patients, prostate cancer
Author NameAffiliation
Wolfgang LillebyOslo University Hospital
Henrik Gr??nbergKarolinska Institute
Henrik Gr??nbergKarolinska Institute
Fredrik WiklundKarolinska Institute
David E NealUniversity of Oxford
Vincent J GnanapragasamUniversity of Cambridge
Vincent J GnanapragasamCambridge University Hospitals NHS Foundation Trust
Vincent J GnanapragasamCambridge Urology Translational Research and Clinical Trials
Ian G MillsUniversity of Oslo and Oslo University Hospital
Ian G MillsUniversity of Cambridge
Ian G MillsUniversity of Oxford
Ian G MillsOslo University Hospitals
Ian G MillsOslo University Hospitals
Ian G MillsQueen's University Belfast
  • 1 - 14

Datasets

Release 1.2